::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::

CODEN : IAJPBB
issn 2349-7750

News Updates Latest Volumes: COSMOS IMPACT FACTOR (2018)- 4.153, GLOBAL IMPACT FACTOR(2014) - 0.384, (2015) - 0.437, Indo American Journal of Pharmaceutical Sciences,

ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

RATE OF RECURRENCE OF GASTROESOPHAGEAL REFLUX DISEASE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS: A CROSS SECIONAL STUDY

AUTHORS:

Ayesha Ali Khan, Muhammad Talha Anwar, Ramsha Irum

ABSTRACT:

Objective: The aim of this study is to assess the percentage of the Gastroesophageal Reflux Disease (GERD) in the patients of Chronic Obstructive Pulmonary Disease (COPD). Material and Methods: The design of this study was cross-sectional study Allied / DHQ Hospital Faisalabad and the duration of this study was from June 2019 to June 2020. 112 patients were enrolled in our study who fulfilled the criteria for inclusion and established diagnosis of the COPD i.e., patients having age more than 40, with history of >20 pack years of smoking and FEV/FVC less than 0.7. Results: In this study 36% of the patients were in the age group 41-55 years and 64% were of age more than 55 years. The mean age of patients was 56.86±7.51, out of 112 patients, the percentage of males was 83% and that of females 17%. Conclusion: It was assessed from the study results that the 43% of the COPD patients also suffered from GERD. So, to put a control on repeated Exacerbations of the disease proper surveillance of the GERD should be initiated of every COPD patient on his first arrival. Keywords: Gastroesophageal Reflux Disease, Vagal Nerve stimulation, Chronic Obstructive Pulmonary Disease, Disease Surveillance, Pulmonary